Feature Channels

AIDS and HIV

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Keywords:

Research Shows Anti-HIV Medicines Can Cause Damage to Fetal Hearts

Just-published findings in the journal AIDS raise concern about potential long-term harmful impact of “antiretroviral therapy” on in-utero infants whose mothers are HIV-positive, but who are not infected with HIV themselves.

View | Comment

Medicine

Channels:

Keywords:

HIV/AIDS Drugs Could Be Repurposed to Treat Age-Related Macular Degeneration

A landmark study published today in the journal Science by an international group of scientists, led by the laboratory of Dr. Jayakrishna Ambati, professor and vice chair of the Department of Ophthalmology & Visual Sciences at the University of Kentucky, reports that HIV/AIDS drugs that have been used for the last 30 years could be repurposed to treat age-related macular degeneration (AMD), as well as other inflammatory disorders, because of a previously undiscovered intrinsic and inflammatory activity those drugs possess.

View | Comment

Medicine

Channels:

Keywords:

A Palliative Caregiver for Young Lives Cut Short

IMG_1091hires.jpg

In the 1980s, when HIV/AIDS was a new, mysterious and inevitably fatal illness, Dr. James Oleske of what is new Rutgers New Jersey Medical School earned renown for caring for children who would inevitably die from AIDS, and for uncovering some of its important secrets. With HIV under much better control, Oleske has now turned his attention to being a champion of palliative care for children who are terribly ill with other fatal conditions.

View | Comment

Medicine

Channels:

Keywords:

HIV-Infected Adults Diagnosed with Age-Related Diseases at Similar Ages as Uninfected Adults

New research from the Johns Hopkins Bloomberg School of Public Health suggests that HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV.

View | Comment

Medicine

Channels:

Keywords:

Tourism as a Driver of Illicit Drug Use, HIV Risk in the D.R.

The study’s results suggest three themes: (1) local demand shifts drug routes to tourism areas, (2) drugs shape local economies and (3) drug use facilitates HIV risk behaviors in tourism areas.

View | Comment

Science

Channels:

Keywords:

A New Dent in HIV-1’s Armor

Salk scientists identify a promising target for HIV/AIDS treatment

View | Comment

Medicine

Life

Education

Channels:

Keywords:

Bringing HIV Message Home

Feature_HIVCareCorps_SideBar_Willa.jpg

Student, alumni interest in care and prevention are alive and well at Hopkins School of Nursing and beyond.

View | Comment

Medicine

Channels:

Keywords:

Antiretroviral Therapy Benefits HIV-infected Stimulant Users

New clinical research from UC San Francisco shows that 341 HIV-infected men who reported using stimulants such as methamphetamine or cocaine derived life-saving benefits from being on antiretroviral therapy that were comparable to those of HIV-infected men who do not use stimulants.

View | Comment

Science

Channels:

Keywords:

Mymetics’ Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute

Mymeticslogo.png

Mymetics Corporation (OTCQB: MYMX) announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm results obtained in a previous trial. Research is to be funded by the Bill & Melinda Gates Foundation. The study will be led by Dr. Ruth Ruprecht, Scientist & Director of the Texas Biomed AIDS Research Program.

View | Comment

Medicine

Science

Channels:

Keywords:

Surprising Diversity of Antibody Family Provides Clues for HIV Vaccine Design

burton_dennis.jpg

Scientists at The Scripps Research Institute (TSRI) have described how a single family of antibodies that broadly neutralizes different strains of HIV has evolved remarkably diverse structures to attack a vulnerable site on the virus. The findings provide clues for the design of a future HIV vaccine.

View | Comment